VA - (1 Mos. Pre-Separation) | |||||||
Code | Rating | Condition | Code | Rating | Exam | ||
Asthma | 6602 | 10% | Asthma | 6602 | 30% | 20050207 | |
Other x 4 | 20050207 | ||||||
Combined: 40% |
MEB ~9 Mo. Pre-Sep |
VA ~ 1 Mo. Pre-Sep |
||
63.6% | 110% | ||
102.5% | N/A | ||
At time of diagnosis. 27% FEV1 increased response to bronchodilator. |
Post treatment since diagnosis and treatment with A lbuterol, Advair, and Singulair. | ||
30% (PEB 10%) | 30% |
VASRD CODE | RATING | ||
Asthma | 6602 | 30% | |
30% |
AF | PDBR | CY2013 | PD-2013-02765
The requested sleep apnea, anxiety, hypertension and rhinitis conditions were not identified by the PEB, and therefore not within the DoDI 6040.44 defined purview of the Board.Any conditions or contention not requested in this application, or otherwise outside the Board’s defined scope of review, remain eligible for future consideration by the Board for Correction of Military Records. Asthma Condition . The PEB TDRL exit rating was 10%,with the disability description stating: “not...
AF | PDBR | CY2013 | PD-2013-01908
Separation Date: 20040617 RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge with severance pay be recharacterized to reflect permanent disability retirement, effective as of the date of his prior medical separation: Physical Disability Board of Review
AF | PDBR | CY2013 | PD-2013-02500
Asthma Condition . The medications in use were not recorded. RECOMMENDATION : The Board, therefore, recommends that there be no re-characterization of the CI’s disability and separation determination.
AF | PDBR | CY2012 | PD2012-00289
The narrative summary (NARSUM), service treatment records (STR), and prior to separation VA C&P examination all indicate that the CI required and used daily inhalational bronchodilator and oral medications which would support a 30% rating IAW VASRD code 6602 (“daily inhalational or oral bronchodilator therapy or inhalational anti-inflammatory medication”) and VASRD §4.97. RECOMMENDATION : The Board recommends that the CI’s prior determination be modified as follows; and, that the discharge...
AF | PDBR | CY2013 | PD-2013-01963
The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the VASRD standards to the unfitting medical condition at the time of separation. The Board next considered that at the time of separation, although the CI’s asthma was relatively well controlled,treatment notes in the STR, the MEB and C&P exams consistently documented use of the anti-inflammatory inhaler and oral bronchodilator medications, with...
AF | PDBR | CY2013 | PD-2013-01970
RATING COMPARISON : Service IPEB – Dated 20050708VA -(7 Mos. Physical Disability Board of Review I have carefully reviewed the evidence of record and the recommendation of the Board.
AF | PDBR | CY2013 | PD-2013-02064
SEPARATION DATE: 20061204 The Board’s assessment of the PEB rating determinations is confined to review of medical records and all available evidence for application of the Veterans Affairs Schedule for Rating Disabilities (VASRD) standards to the unfitting medical condition at the time of separation. Asthma Condition .
AF | PDBR | CY2013 | PD2013 00352
SEPARATION DATE: 20050114 It is limited to those conditions determined by the PEB to be unfitting for continued military service and those conditions identified, but not determined to be unfitting by the PEB when specifically requested by the CI. The Board noted that the NARSUM and multiple entries found in the service treatment record, months prior to separation, documented that daily use of inhaled anti-inflammatory medication (Advair, Azmacort or Flovent)and daily inhalational...
AF | PDBR | CY2012 | PD2012 01210
No other conditions were submitted by the MEB.The PEB adjudicated asthma with VCDand chronic pain left knee conditions as unfitting, rated 30% and 0% respectively,referencing the US Army Physical Disability Agency (USAPDA) pain policy. 660230%10%Asthma with Vocal Cord Dysfunction660230%20020606Chronic Pain, Left Knee In addition, the CI had a VCD that significantly responded to the beta-agonist inhalational medication, Albuterol for which the medication profile in evidence reflects dosing...
AF | PDBR | CY2012 | PD2012 00466
Asthma . The CI continued to be symptomatic despite his maximal medical regimen.At the MEB exam on 30May 2001, approximately 4months prior to separation, the CI reported some improvement in his SOBbut that he still required a pre-exercise rescue inhaler, often needing to halt PT and required additional rescue inhaler use throughout the day. XXXXXXXXXXXXXXXXXX President Physical Disability Board of Review